TELO Live signals | Maximize Profits with Getagraph.com

SELL 123520 min ago

@ $8.43

Issued: 14 Feb 2024 @ 12:26

Return: -22.42%

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 16:00):

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells...

Stats
Today's Volume	73 128.00
Average Volume	60 519.00
Market Cap	193.65M
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0510 (0.78%)

Volume Correlation

Long: 0.21 (neutral)

Short: -0.18 (neutral)

Signal:(60.915) Neutral

Telomir Pharmaceuticals, Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Telomir Pharmaceuticals, Correlation - Currency/Commodity

-0.21
( neutral )

-0.27
( neutral )

0.00
( neutral )

0.23
( neutral )

-0.32
( neutral )

0.02
( neutral )

Financial Reports:

No articles found.

Telomir Pharmaceuticals,

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. It develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy recovery by interrupting and preventing the interleukin-17 induced inflammatory pathways. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. on October 10, 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Baltimore, Maryland.